Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhu, Zhaofeng
LEONARDA-1, NCT05054751: GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer	Completed	3	275	RoW	GB491+ Fulvestrant, test drug + Fulvestrant, Placebo+Fulvestrant, placebo control + Fulvestrant	Genor Biopharma Co., Ltd.	Locally Advanced or Metastatic Breast Cancer	12/22	03/24
NCT05112991: Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer	Recruiting	2	108	RoW	Envafolimab+Lenvatinib, Envafolimab	3D Medicines (Sichuan) Co., Ltd.	Advanced Endometrial Cancer	03/25	10/25
Fu, Chun
NCT05112991: Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer	Recruiting	2	108	RoW	Envafolimab+Lenvatinib, Envafolimab	3D Medicines (Sichuan) Co., Ltd.	Advanced Endometrial Cancer	03/25	10/25